360 results on '"Friedman, Andrzej"'
Search Results
2. Unilateral gamma knife thalamotomy for tremor safety and efficacy in multimodal assessment: a prospective case-control study with two-year follow-up
3. Impact of Physical Exercise on Levodopa Therapy Across Parkinson's Disease Stages.
4. Is brain perfusion a differentiating feature in the comparison of Progressive Supranuclear Palsy Syndrome (PSPS) and Corticobasal Syndrome (CBS)?
5. Long-term incobotulinumtoxinA treatment for chronic sialorrhea: Efficacy and safety over 64 weeks
6. Clinical Phenotypes of Progressive Supranuclear Palsy—The Differences in Interleukin Patterns
7. “New methods of assessing autonomic disorders in Parkinson disease patients: skin-galvanic reaction”
8. Role of orexin in pathogenesis of neurodegenerative parkinsonisms
9. The Possible Role of Iron in Neurodegeneration
10. An example of the application of Mössbauer spectroscopy for determination of concentration of iron in lyophilized brain tissue
11. Could hyperlipidemia be a risk factor for corticobasal syndrome? — a pilot study
12. Sleep disturbances in progressive supranuclear palsy syndrome (PSPS) and corticobasal syndrome (CBS)
13. Thalamic and cerebellar hypoperfusion in single photon emission computed tomography may differentiate multiple system atrophy and progressive supranuclear palsy
14. SIAXI: Placebo-controlled, randomized, double-blind study of incobotulinumtoxinA for sialorrhea
15. Iron in the brain
16. Microbiota Dysbiosis in Parkinson Disease—In Search of a Biomarker
17. The Significance of Asymmetry in the Assessment of Brain Perfusion in Atypical Tauopathic Parkinsonian Syndromes
18. Heterozygous PINK1 p.G411S increases risk of Parkinson’s disease via a dominant-negative mechanism
19. Inflammatory cytokines and NT-proCNP in Parkinson’s disease patients
20. Platelet-to-lymphocyte ratio and neutrophil-tolymphocyte ratio may reflect differences in PD and MSA-P neuroinflammation patterns
21. Small intestine dysfunction in Parkinson’s disease
22. Ferritin as an important player in neurodegeneration
23. The Strengths and Obstacles in the Differential Diagnosis of Progressive Supranuclear Palsy—Parkinsonism Predominant (PSP-P) and Multiple System Atrophy (MSA) Using Magnetic Resonance Imaging (MRI) and Perfusion Single Photon Emission Computed Tomography (SPECT)
24. Neuroimaging in Parkinson’s Disease: necessity or exaggeration?
25. Iron and reactive oxygen species activity in parkinsonian substantia nigra
26. Basal ganglia echogenicity in tauopathies
27. Frequency of mutations in PRKN, PINK1, and DJ1 in Patients With Early-Onset Parkinson Disease from neighboring countries in Central Europe
28. Iron as a cause of Parkinson disease – a myth or a well established hypothesis?
29. The Possible Role of Iron in Neurodegeneration
30. The history of the research of iron in parkinsonian substantia nigra
31. Genetics of Parkinson’s disease in the Polish population
32. Brain tissue echogenicity—implications for substantia nigra studies in parkinsonian patients
33. The matter of significance – Has the p.(Glu121Lys) variant of TOR1A gene a pathogenic role in dystonia or Parkinson disease?
34. Proteomic Profile of Saliva in Parkinson’s Disease Patients: A Proof of Concept Study
35. Mechanisms of Neurodegeneration in Various Forms of Parkinsonism—Similarities and Differences
36. Iron In Neurodegeneration
37. ELISA reveals a difference in the structure of substantia nigra ferritin in Parkinson's disease and incidental Lewy body compared to control
38. Neutrophil-to-lymphocyte ratio (NLR) at boundaries of Progressive Supranuclear Palsy Syndrome (PSPS) and Corticobasal Syndrome (CBS)
39. The Role of Frontal Assessment Battery and Frontal Lobe Single-Photon Emission Computed Tomography in the Differential Diagnosis of Progressive Supranuclear Palsy Variants and Corticobasal Syndrome—A Pilot Study
40. Iron and ferritin in hippocampal cortex and substantia nigra in human brain — Implications for the possible role of iron in dementia
41. Influence of Bilateral Subthalamic Nucleus Deep Brain Stimulation on the Lipid Profile in Patients With Parkinson's Disease
42. Microglial Activation and Inflammation as a Factor in the Pathogenesis of Progressive Supranuclear Palsy (PSP)
43. Parkinson's disease or atypical parkinsonism? The importance of acoustic voice analysis in differential diagnosis of speech disorders
44. Cerebral Hypoperfusion in Progressive Supranuclear Palsy (PSP) and Corticobasal Syndrome (CBS)
45. PARK2, PINK1, and DJ1 in patients with early-onset Parkinson’s disease in four European countries. (2506)
46. Progressive Supranuclear Palsy—Parkinsonism Predominant (PSP-P)—A Clinical Challenge at the Boundaries of PSP and Parkinson's Disease (PD)
47. In search of Parkinson’s disease biomarkers — is the answer in our mouths? A systematic review of the literature on salivary biomarkers of Parkinson’s disease
48. DIAGNOSIS OF AUTONOMIC DISORDERS IN PARKINSON’S DISEASE
49. Serum levels of hepcidin and interleukin 6 in Parkinson’s disease
50. Iron as a trigger of neurodegeneration in Parkinson's disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.